Detalhe da pesquisa
1.
H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Pediatric High-Grade Gliomas.
bioRxiv
; 2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37398299
2.
Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy.
ACS Nano
; 16(6): 8729-8750, 2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35616289
3.
Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice.
J Clin Invest
; 131(4)2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332283
4.
Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma.
Clin Cancer Res
; 26(15): 4080-4092, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32332014
5.
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures.
J Vis Exp
; (143)2019 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30688315
6.
High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme.
ACS Nano
; 13(2): 1365-1384, 2019 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30721028
7.
IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.
Sci Transl Med
; 11(479)2019 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30760578
8.
Melanoma induced immunosuppression is mediated by hematopoietic dysregulation.
Oncoimmunology
; 7(3): e1408750, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29399415